Transsexual pustules psoriasis: Imsidolimab named FDA orphan drug
Last Update: 2020-07-14
Search more information of high quality chemicals, good prices and reliable suppliers, visit
Biotech company AnaptysBio announced today that the U.S
has awarded the anti-white interleukin 36 receptor (IL-36R) antibody imsidolimab orphan drug for the treatment of patients with dyslezotic pustulitous psoriasis (GPP)
Hamza Suria, President and CEO of Anaptys Bio, said, "The orphan drug designation is an important milestone in the imsidolimab program
We look forward to advancing the clinical development of imsidolimab in GPP, PPP and other clinical indications that may be driven by IL-36R signal disorders."
GPP is a life-threatening rare disease and currently has no approved treatment
It is estimated that there are approximately 3,000 cases of GPP patients in the United States
psoriasis can occur independently or on the basis of the original psoriasis, and the distribution may be generalized or limited
Generalized pustules psoriasis (GPP) is acute or subacute and manifests itself as a pustules rash widely distributed on the inflamed erythema skin
Limitation pustules psoriasis mainly affects the palm, foot or finger
Partially prociatic or limited pustules psoriasis may actually be a new hereditary autoinflammatory disease based on the IL-36 receptor antagonist (IL-36Ra) mutation
Other specific genetic abnormalities were also found in patients with pustules psoriasis
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to email@example.com
. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.